These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recovery from LCDD-associated Severe Liver Cholestasis: a Case Report and Literature Review. Brilland B; Sayegh J; Croue A; Bridoux F; Subra JF; Augusto JF J Gastrointestin Liver Dis; 2016 Mar; 25(1):99-103. PubMed ID: 27014760 [TBL] [Abstract][Full Text] [Related]
3. κ I light chain AL amyloidosis presenting with rapidly progressive renal and hepatic failure with unusual renal amyloid distribution. Oe Y; Nakaya I; Yahata M; Murata O; Yaegashi H; Sakuma T; Sato H; Liepnieks JJ; Benson MD; Soma J Clin Nephrol; 2012 Jan; 77(1):66-70. PubMed ID: 22185971 [TBL] [Abstract][Full Text] [Related]
4. Light chain deposition disease of the liver without renal involvement in a patient with multiple myeloma related to liver failure and rapid fatal outcome. Michopoulos S; Petraki K; Petraki C; Dimopoulos MA Dig Dis Sci; 2002 Apr; 47(4):730-4. PubMed ID: 11991600 [TBL] [Abstract][Full Text] [Related]
5. [Acute Liver Failure in patient with liver amyloidosis associated to multiple myeloma]. Berríos M; Armas-Merino R; Franco C; Parrochia E; Wolff C Rev Med Chil; 2003 Nov; 131(11):1301-4. PubMed ID: 14743692 [TBL] [Abstract][Full Text] [Related]
6. [Jaundice secondary to intrahepatic deposit of light chains as a presenting form of multiple myeloma]. Macías Robles MD; Navia-Osorio García-Braga JM; Menéndez Caro JL; Velasco Alonso J; López Lagunas I An Med Interna; 1994 Feb; 11(2):74-6. PubMed ID: 8193237 [TBL] [Abstract][Full Text] [Related]
7. Development of rapidly progressive liver light chain deposition under VAD chemotherapy in multiple myeloma. Samanez C; Domingo A; Cibeira MT; Miquel R; Soler M; Bladé J Eur J Haematol; 2006 Jan; 76(1):83-5. PubMed ID: 16343276 [TBL] [Abstract][Full Text] [Related]
8. Jaundice revealing a k light chain myeloma because of liver light chain deposits. Montialoux H; Savoye G; Savoye-Collet C; Ramirez S; François A; Lerebours E; Goria O Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):827-9. PubMed ID: 19404208 [TBL] [Abstract][Full Text] [Related]
9. Portal hypertension and acute liver failure as uncommon manifestations of primary amyloidosis. Norero B; Pérez-Ayuso RM; Duarte I; Ramirez P; Soza A; Arrese M; Benítez C Ann Hepatol; 2013 Jan-2014 Feb; 13(1):142-9. PubMed ID: 24378278 [TBL] [Abstract][Full Text] [Related]
10. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Pozzi C; D'Amico M; Fogazzi GB; Curioni S; Ferrario F; Pasquali S; Quattrocchio G; Rollino C; Segagni S; Locatelli F Am J Kidney Dis; 2003 Dec; 42(6):1154-63. PubMed ID: 14655186 [TBL] [Abstract][Full Text] [Related]
11. Light chain deposition disease involving kidney and liver in a patient with IgD myeloma. Tsushima T; Suzuki T; Terao T; Miura D; Narita K; Takeuchi M; Shimuzu A; Matsue K BMC Nephrol; 2021 Jan; 22(1):40. PubMed ID: 33485303 [TBL] [Abstract][Full Text] [Related]
12. Multiple Myeloma Light Chain Amyloidosis Presenting as Hepatic Failure. Elgouhari H; Ahmed K; Niazi M; Huntington MK S D Med; 2018 Mar; 71(3):112-115. PubMed ID: 29991097 [TBL] [Abstract][Full Text] [Related]
13. [The concurrence of light-chain deposition disease, AL-amyloidosis, and cast nephropathy in a patient with multiple myeloma]. Rekhtina IG; Zakharova EV; Stolyarevich ES; Sinitsina MN; Denisova EN Ter Arkh; 2015; 87(6):98-101. PubMed ID: 26281203 [TBL] [Abstract][Full Text] [Related]
14. Plasma cell myeloma initially diagnosed as light-chain deposition disease on liver biopsy: A case report and literature review. Jeong JY; Yang HT; Cho SH; Lee YR; Kim J; Kang MK; Hong J; Moon JH; Seo AN Medicine (Baltimore); 2023 Mar; 102(13):e33406. PubMed ID: 37000077 [TBL] [Abstract][Full Text] [Related]
15. [Myeloma and the kidney]. Linnanvuo-Laitinen M; Huttunen K; Timonen T Duodecim; 1987; 103(1):42-6. PubMed ID: 3111820 [No Abstract] [Full Text] [Related]
16. Development of rapid light-chain deposition disease in hepatic arteries with severe ischemic cholangitis in a multiple myeloma patient treated with melphalan, prednisone and lenalidomide. Weisel KC; Böckeler M; Bianchi L; Terracciano LM; Mayer F; Kanz L Int J Hematol; 2009 Jan; 89(1):91-94. PubMed ID: 19101782 [TBL] [Abstract][Full Text] [Related]
17. Structural peculiarities of a truncated V kappa III immunoglobulin light chain in myeloma with light chain deposition disease. Decourt C; Cogné M; Rocca A Clin Exp Immunol; 1996 Nov; 106(2):357-61. PubMed ID: 8918585 [TBL] [Abstract][Full Text] [Related]